Nyhetsflöde

Regulatoriska pressmeddelanden

Icke regulatoriska pressmeddelanden och nyheter

12 april 2021

THIS IS BEYOND. Such an inspiring and hopeful story our colleague PSyD Gery-Lynn Utter brings to her important work… https://t.co/LqjD2va8er

8 april 2021

To avoid being captured in the vicious circle of #addiction there is a need of counselling support to cope with AUD… https://t.co/wcpUZLvlap

7 april 2021

Ethypharm acquires the rights to deprexis & vorvida in 4 European countries from our partner @GAIA_COM. Yet another… https://t.co/USDN34EMMN

Europa

USA

Lena Wange

IR & Corporate Communications Director

Växel: +46 (0)18 780 88 00

Direktnummer: +48 73 064 16 36

Email: ir@orexo.com

Plats: Uppsala, Sverige

Dennis Urbaniak

EVP Digital Therapeutics

Växel: +1 (0)855 982 7658

Direktnummer: +1 973 294 3183

Email: us.media@orexo.com

Plats: New Jersey, USA